Belgium vs France: Cause of death, by non-communicable diseases, ages 5-14
Belgium
64.1%
in 2021
France
64.5%
in 2021
Belgium rank
21st
France rank
20th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Belgium
- France
How they compare
France currently reports 64.5% against 64.1% in Belgium, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was France ahead.
Belgium ranks 21st and France ranks 20th of 185 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and France in 2.
Head to head by decade
| Decade | Belgium | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.6% | 51.7% | 9.1% | France |
| 2010s | 60.0% | 65.8% | 5.8% | France |
| 2020s | 63.6% | 63.4% | 0.2% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Belgium or France?
- France, at 64.5% against 64.1% in Belgium as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Belgium and France?
- 0.4%, with France ahead.
- How many years of comparable data are there for Belgium and France?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and France rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Belgium ranks 21st and France ranks 20th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.